We are live on
!
Find out more
BG
Bahl & Gaynor Portfolio holdings
AUM
$19.8B
1-Year Est. Return
19.53%
This Fund
S&P 500
This Quarter
Est. Return
+7.27%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$7.78B
AUM Growth
-$1.78B
(-19%)
Cap. Flow
-$2.37B
Cap. Flow
% of AUM
-30.47%
Top 10 Holdings %
Top 10 Hldgs %
29.96%
Holding
369
New
5
Increased
87
Reduced
226
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$53.7M |
| 2 |
Baxter International
BAX
|
+$17.4M |
| 3 |
Eli Lilly
LLY
|
+$16.3M |
| 4 |
US Bancorp
USB
|
+$10.3M |
| 5 |
Healthcare Services Group
HCSG
|
+$3.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$140M |
| 2 |
JPMorgan Chase
JPM
|
+$111M |
| 3 |
Texas Instruments
TXN
|
+$106M |
| 4 |
Cisco
CSCO
|
+$93.4M |
| 5 |
NextEra Energy
NEE
|
+$90.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.36% |
| 2 | Healthcare | 17.22% |
| 3 | Financials | 14.15% |
| 4 | Industrials | 11.02% |
| 5 | Consumer Staples | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Gilead Sciences
GILD
$165B
| $1.73M | 0.02% |
22,341
| – | – |
|
227
Texas Pacific Land
TPL
$24.4B
| $1.73M | 0.02% |
18,000
| – | – |
|
228
Flowers Foods
FLO
$1.56B
| $1.71M | 0.02% |
91,820
-44,602
| -33% | -$901K |
|
229
Goldman Sachs
GS
$302B
| $1.68M | 0.02% |
7,511
-2,250
| -23% | -$523K |
|
|
ATRI
230
DELISTED
Atrion Corp
ATRI
| $1.67M | 0.02% |
2,407
+77
| +3% | +$49.5K |
|
231
Mastercard
MA
$496B
| $1.67M | 0.02% |
7,490
-578
| -7% | -$121K |
|
232
Kraft Heinz
KHC
$29.8B
| $1.65M | 0.02% |
29,988
-5,207
| -15% | -$311K |
|
233
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $1.61M | 0.02% |
39,268
+2,420
| +7% | +$102K |
|
234
DuPont de Nemours
DD
$19.6B
| $1.59M | 0.02% |
9,781
+583
| +6% | +$100K |
|
235
Barrett Business Services
BBSI
$809M
| $1.59M | 0.02% |
95,296
+2,120
| +2% | +$42.9K |
|
236
Zimmer Biomet
ZBH
$18.3B
| $1.57M | 0.02% |
12,322
-195
| -2% | -$23.2K |
|
237
D.R. Horton
DHI
$41.4B
| $1.55M | 0.02% |
36,777
+1,475
| +4% | +$63.8K |
|
238
Cracker Barrel
CBRL
$1.29B
| $1.54M | 0.02% |
10,499
-5,147
| -33% | -$771K |
|
239
National Healthcare
NHC
$3.41B
| $1.48M | 0.02% |
19,676
-3,071
| -14% | -$226K |
|
240
C.H. Robinson
CHRW
$17.3B
| $1.46M | 0.02% |
14,856
-4,769
| -24% | -$447K |
|
241
Azenta
AZTA
$1.44B
| $1.44M | 0.02% |
41,048
+1,415
| +4% | +$46.5K |
|
|
CY
242
DELISTED
Cypress Semiconductor
CY
| $1.43M | 0.02% |
98,629
-17,919
| -15% | -$295K |
|
|
FLIR
243
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $1.41M | 0.02% |
22,938
-31
| -0.1% | -$1.82K |
|
244
Amdocs
DOX
$6.22B
| $1.4M | 0.02% |
21,169
+155
| +0.7% | +$10.3K |
|
245
General Mills
GIS
$19.4B
| $1.34M | 0.02% |
31,215
-3,763
| -11% | -$170K |
|
246
American Financial Group
AFG
$12.1B
| $1.33M | 0.02% |
11,977
+180
| +2% | +$20K |
|
247
Meta Platforms (Facebook)
META
$1.52T
| $1.33M | 0.02% |
8,078
-146
| -2% | -$26.4K |
|
248
Agilent Technologies
A
$40.5B
| $1.32M | 0.02% |
18,763
+9,874
| +111% | +$653K |
|
249
Thor Industries
THO
$4.08B
| $1.31M | 0.02% |
15,671
+57
| +0.4% | +$5.45K |
|
|
RTN
250
DELISTED
Raytheon Company
RTN
| $1.29M | 0.02% |
6,253
-100
| -2% | -$19.9K |
|
Similar funds
NIM
HHII
SPIA
MIM
EIM
OSAM
P
Bahl & Gaynor's Q3 2018 Portfolio in Review
As of Q3 2018, Bahl & Gaynor held 369 positions worth $7.78B, down 19% from $9.56B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bahl & Gaynor withdrew a net $2.37B in Q3 2018, closing 9 positions and reducing 226 holdings. Its most notable exit was Pinnacle Foods, Inc., an estimated $3.95M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Bahl & Gaynor opened a new position in Northrop Grumman worth $2.52M.
- Bahl & Gaynor's largest Q3 2018 buy was Northrop Grumman: 7,945 shares worth $2.52M.
- Bahl & Gaynor added most to Starbucks in Q3 2018, an estimated $53.7M increase.
- Bahl & Gaynor's biggest Q3 2018 reduction was Microsoft, cutting an estimated $140M.
- Bahl & Gaynor fully exited Pinnacle Foods, Inc. in Q3 2018, selling an estimated $3.95M.
- Bahl & Gaynor's ten largest holdings make up 30% of its $7.78B portfolio in Q3 2018.
- Bahl & Gaynor opened 5 new positions and closed 9 in Q3 2018.
- Bahl & Gaynor's portfolio value fell 19% quarter-over-quarter to $7.78B.
Based on Bahl & Gaynor's 13F filing for Q3 2018, filed 9 Nov 2018.